NOTCH1 and acute lymphoblastic leukemia: Treatment of T-ALL cell lines with MRK-560 targeting the catalytic subclass of the γ-secretase complex has been demonstrated to decrease mutant NOTCH1 processing and lead to cell cycle arrest, and the toxicity can be tolerated [374].